{"url_path":"/sec/ntrbw/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 Exhibits.**","topic":"sec","document":{"doc_type":"10-K/A","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1676047/0001213900-26-058507-index.html","accession_number":"0001213900-26-058507","cik":"0001676047","ticker":"NTRB","issuer_name":"NutriBand Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1676047/0001213900-26-058507-index.html","primary_entity_key":"0001676047","primary_entity_name":"NutriBand Inc."},"word_count":1539,"has_tables":true,"body_markdown":"**ITEM 15 Exhibits.**\n\n \n\n**Exhibit**\n \n \n\n**Number**\n \n**Description**\n\n1.1\n \n[Reserved]\n\n3.1A\n \n[Articles of Incorporation.(1)](http://www.sec.gov/Archives/edgar/data/1676047/000121390016013961/f1012g2016ex3ia_nutriband.htm)\n\n3.1B\n \n[Amendment to Articles of Incorporation, filed May 12, 2016.(1)](http://www.sec.gov/Archives/edgar/data/1676047/000121390016013961/f1012g2016ex3ib_nutriband.htm)\n\n3.1\n \n[Certificate of Amendment filed January 21, 2020. (Filed as Exhibit 3.1 to the Company’s Current Report](http://www.sec.gov/Archives/edgar/data/1676047/000121390020001906/f8k012120ex3-1_nutribandinc.htm) [on Form 8-K, filed January 27, 2020).](http://www.sec.gov/Archives/edgar/data/1676047/000121390020001906/f8k012120ex3-1_nutribandinc.htm)\n\n3.1C\n \n[Certificate of Change, filed with the Nevada Secretary of State on August 4, 2022.(13)](http://www.sec.gov/Archives/edgar/data/1676047/000121390022046093/ea164097ex3-1c_nutriband.htm)\n\n3.1D\n \n[Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on July 16, 2025.(21)](https://www.sec.gov/Archives/edgar/data/1676047/000121390025064355/ea024911601ex3-1d_nutri.htm)\n\n3.2\n \n[By-laws(1)](http://www.sec.gov/Archives/edgar/data/1676047/000121390016013961/f1012g2016ex3ii_nutriband.htm)\n\n3.2B\n \n[Amended and Restated By-Laws adopted January 21, 2022.(12)](http://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/ea154565ex3-2a_nutriband.htm)\n\n4.3\n \n[Securities purchase agreement dated October 29, 2019 among the Company, Jefferson Street Capital LLC](http://www.sec.gov/Archives/edgar/data/1676047/000121390019021870/f8k103019ex4-1_nutriband.htm) [and Platinum Point Capital LLC(6)](http://www.sec.gov/Archives/edgar/data/1676047/000121390019021870/f8k103019ex4-1_nutriband.htm)\n\n4.4\n \n[Form of convertible 6% promissory note issued pursuant to Exhibit 4.3 (6)](http://www.sec.gov/Archives/edgar/data/1676047/000121390019021870/f8k103019ex4-2_nutriband.htm)\n\n4.10\n \n[Form of Common Stock Purchase Warrant issued to Platinum Point Capital LLC and Jefferson Street](http://www.sec.gov/Archives/edgar/data/1676047/000121390019021870/f8k103019ex4-3_nutriband.htm) [Capital LLC(6)](http://www.sec.gov/Archives/edgar/data/1676047/000121390019021870/f8k103019ex4-3_nutriband.htm)\n\n4.14†\n \n[2021 Employee Stock Option Plan.(11)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021057079/ea149845ex10-1_nutribandinc.htm)\n\n4.15†\n \n[Form of Stock Option Grant Notice.(11)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021057079/ea149845ex10-2_nutribandinc.htm)\n\n4.16\n \n[Form of Common Stock Purchase Warrant issued in the Company’s initial public offering in 2021(9)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021050881/ea148206ex4-12_nutriband.htm)\n\n4.17\n \n[Form of Warrant issued to the Representative.(14)](http://www.sec.gov/Archives/edgar/data/1676047/000121390023051508/ea180127ex4-17_nutribandinc.htm)\n\n4.18†\n \n[2024 Amended and Restated Stock Option Plan, adopted March 20, 2024.(15)](http://www.sec.gov/Archives/edgar/data/1676047/000121390024027338/ea020284801ex4-16_nutri.htm)\n\n4.19\n \n[Form of Common Stock Purchase Warrant issued in 2024 Equity Financi1ng (18)](http://www.sec.gov/Archives/edgar/data/1676047/000121390024035276/ea020449001ex4-19_nutriband.htm)\n\n5.1\n \n[Reserved]\n\n10.1\n \n[Share exchange agreement dated January 15, 2016 by and among the Company, Nutriband Limited, an](http://www.sec.gov/Archives/edgar/data/1676047/000121390016013961/f1012g2016ex10i_nutriband.htm) [Ireland corporation, and Gareth Sheridan and/or his nominee(1)](http://www.sec.gov/Archives/edgar/data/1676047/000121390016013961/f1012g2016ex10i_nutriband.htm)\n\n10.4\n \n[Acquisition agreement dated April 5, 2018 between the Company and 4P Therapeutics LLC.(3)](http://www.sec.gov/Archives/edgar/data/1676047/000121390018004227/f8k041018ex99-2_nutriband.htm)\n\n10.5†\n \n[Form of agreement with independent directors.(4)](http://www.sec.gov/Archives/edgar/data/1676047/000121390019006792/f10k2019ex10-4_nutribandinc.htm)\n\n10.6\n \n[Exclusive master distribution agreement dated April 13, 2018 between the Company and EMI-Korea](http://www.sec.gov/Archives/edgar/data/1676047/000121390019006792/f10k2019ex10-5_nutribandinc.htm) [(Best Choice), Inc.(4)](http://www.sec.gov/Archives/edgar/data/1676047/000121390019006792/f10k2019ex10-5_nutribandinc.htm)\n\n10.15†\n \n[Employment Agreement, dated April 23, 2019, between Gareth Sheridan and the Company.(5)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020012861/ea122002ex10-15_nutriband.htm)\n\n10.16†\n \n[Employment Agreement, dated April 23, 2019, between Serguei Melnik and the Company.(5)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020012861/ea122002ex10-16_nutriband.htm)\n\n10.17†\n \n[Employment Agreement, dated February 19, 2019, between Jeffrey Patrick and the Company.(5)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020012861/ea122002ex10-17_nutriband.htm)\n\n10.18†\n \n[Employment Agreement, dated January 1, 2018, between Sean Gallagher and the Company.(5)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020012861/ea122002ex10-18_nutriband.htm)\n\n10.19\n \n[Purchase Agreement, dated August 31, 2020, by and among the Company and Pocono Coated Products,](http://www.sec.gov/Archives/edgar/data/1676047/000121390020025377/ea126478ex10-19_nutribandinc.htm) [LLC.(7)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020025377/ea126478ex10-19_nutribandinc.htm)\n\n \n\n2\n\n \n\n \n\n10.20\n \n[Security Agreement, between the Company and Pocono Coated Products, LLC.(7)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020025377/ea126478ex10-20_nutribandinc.htm)\n\n10.21\n \n[Promissory Note Issued by the Company on August 31, 2020 to Pocono Coated Products, LLC.(7)](http://www.sec.gov/Archives/edgar/data/1676047/000121390020025377/ea126478ex10-21_nutribandinc.htm)\n\n10.22\n \n[License Agreement, dated December 9, 2020, between the Company and Rambam Med-Tech Ltd.(8)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021014753/ea137408ex10-22_nutriband.htm)\n\n10.23\n \n[Distribution Agreement, dated March 26, 2021, between the Company and BPM Inno Ltd.(8)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021014753/ea137408ex10-23_nutriband.htm)\n\n10.24\n \n[Stock Purchase Agreement, dated December 7, 2020, between the Company and BPM Inno Ltd.(8)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021014753/ea137408ex10-24_nutriband.htm)\n\n10.25\n \n[Amendment No. 1 to Purchase Agreement, dated August 31, 2020, by and among the Company and](http://www.sec.gov/Archives/edgar/data/1676047/000121390021046170/ea146824ex10-25_nutriband.htm) [Pocono Coated Products, LLC(8a)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021046170/ea146824ex10-25_nutriband.htm)\n\n10.26\n \n[Services Agreement dated October 4, 2021, between Active Intelligence, LLC and Diomics](http://www.sec.gov/Archives/edgar/data/1676047/000121390021052451/ea148731ex10-26_nutriband.htm) [Corporation.(10)](http://www.sec.gov/Archives/edgar/data/1676047/000121390021052451/ea148731ex10-26_nutriband.htm)\n\n10.27†\n \n[Employment Agreement effective February 1, 2022, between the Company and Gareth Sheridan.(12)](http://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/ea154565ex10-27_nutriband.htm)\n\n10.28†\n \n[Employment Agreement effective February 1, 2022, between the Company and Serguei Melnik.(12)](http://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/ea154565ex10-28_nutriband.htm)\n\n10.29†\n \n[Employment Agreement effective February 1, 2022, between the Company and Gerald Goodman.(12)](http://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/ea154565ex10-29_nutriband.htm)\n\n10.30\n \n[Creditline Promissory Note, dated July 13, 2023. (16)](http://www.sec.gov/Archives/edgar/data/1676047/000121390023056939/ea181821ex10-30_nutriband.htm)\n\n10.31\n \n[Conversion Agreement, dated December 19, 2023.(17)](http://www.sec.gov/Archives/edgar/data/1676047/000121390023100093/ea190927ex10-31_nutriband.htm)\n\n10.32\n \n[Form of Subscription Agreement for April 19, 2024 Equity Financing (19)](https://www.sec.gov/Archives/edgar/data/1676047/000121390024035276/ea020449001ex10-32_nutriband.htm)\n\n10.33\n \n[Form of Note Conversion Agreement dated May 13, 202420](https://www.sec.gov/Archives/edgar/data/1676047/000121390024045330/ea020654401ex10-33_nutri.htm)\n\n10.35\n \n[Commercial Development and Clinical Supply Agreement (“Agreement”), made on January 4, 2023, between Kindeva Drug Delivery, L.P. and 4P Therapeutics, LLC., filed as Exhibit 10.35 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 28, 2025.](http://www.sec.gov/Archives/edgar/data/1676047/000121390025036201/ea023904801ex10-35_nutriband.htm)\n\n10.36\n \n[Amendment No. 1, dated as of February 4, 2025, to the Commercial Development and Clinical Supply Agreement, by and between Kindeva Drug Delivery L.P. and 4P Therapeutics, LLC., filed as Exhibit 10.36 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 28, 2025.](http://www.sec.gov/Archives/edgar/data/1676047/000121390025036201/ea023904801ex10-36_nutriband.htm)\n\n21.1\n \n[List of Subsidiaries of Nutriband Inc.(14)](http://www.sec.gov/Archives/edgar/data/1676047/000121390023051508/ea180127ex21-1_nutribandinc.htm)\n\n23.1\n \n[Reserved]\n\n31.1\n \n[Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.*](ea029087401ex31-1.htm)\n\n31.2\n \n[Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.*](ea029087401ex31-2.htm)\n\n32.1\n \n[Certification of the Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley.*](ea029087401ex32-1.htm)\n\n32.2\n \n[Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley.*](ea029087401ex32-2.htm)\n\n97.1\n \n[Executive Compensation Clawback Policy†*](ea029087401ex97-1.htm)\n\n101.INS\n \nInline XBRL Instance Document.*\n\n101.SCH\n \nInline XBRL Taxonomy Extension Schema Document.*\n\n101.CAL\n \nInline XBRL Taxonomy Extension Calculation Linkbase Document.*\n\n101.DEF\n \nInline XBRL Taxonomy Extension Definition Linkbase Document.*\n\n101.LAB\n \nInline XBRL Taxonomy Extension Label Linkbase Document.*\n\n101.PRE\n \nInline XBRL Taxonomy Extension Presentation Linkbase Document.*\n\n104\n \nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n107\n \nFiling Fee Table\n\n \n\n*\nFiled herewith.\n\n \n \n\n†\nExecutive compensation plan or arrangement.\n\n \n \n\n(1)\nFiled as exhibit to the Company’s registration statement on Form 10, which was filed with the Commission on June 2, 2016, and incorporated herein by reference.\n\n \n\n(2)\nFiled as an exhibit to the Company’s report on Form 8-K, which was filed with the Commission on January 27, 2020 and incorporated herein by reference.\n\n \n \n\n(3)\nFiled as an exhibit to the Company’s report on Form 8-K, which was filed with the Commission on April 10, 2018 and incorporated herein by reference.\n\n \n \n\n(4)\nFiled as an exhibit to the Company’s annual report on Form 10-K for the year ended January 3, 2019 which was filed with the Commission on April 19, 2019, and incorporated herein by reference.\n\n \n\n3\n\n \n\n \n\n(5)\nFiled as an exhibit to the Company’s Registration Statement on Form S-1/A, which was filed with the Commission on May 19, 2020, and incorporated herein by reference.\n\n \n\n(6)\nFiled as an exhibit to the Company’s report on Form 8-K, which was filed with the Commission on November 4, 2019, and incorporated herein by reference.\n\n \n\n(7)\nFiled as an exhibit to the Company’s report on Form 8-K, which was filed with the Commission on September 4, 2020, and incorporated herein by reference.\n\n \n \n\n(8)\nFiled as exhibits to the Company’s report on Form 8-K, which was filed with the Commission on March 11, 2021, and incorporated herein by reference.\n\n \n \n\n(8a)\nFiled as an exhibit to the Company’s report on Form 8-K, which was filed with the Commission on September 1, 2021, and incorporated herein by reference.\n\n \n \n\n(9)\nFiled as Exhibit 4.12 to Amendment 2 to the Company’s Registration Statement on Form S-1, which was filed with the Commission on October 1, 2021.\n\n \n \n\n(10)\nFiled as an exhibit to the Company’s Current Report on Form 8-K, which was filed with the Securities and Exchange Commission on October 12, 2021, and incorporated herein by reference.\n\n \n \n\n(11)\nFiled as an exhibit to the Company’s Registration Statement on Form S-8, which was filed with the Commission on November 5, 2021, and incorporated herein by reference.\n\n \n \n\n(12)\nFiled as an exhibit to the Company’s Current Report on Form 8-K, which was filed with the Commission on January 27, 2022, and incorporated herein by reference.\n\n \n \n\n(13)\nFiled as Exhibit 3.1C to the Company’s Current Report on Form 8-K, which was filed with the Commission on August 10, 2022, and incorporated herein by reference.\n\n \n \n\n(14)\nFiled as an exhibit to the Company’s Registration Statement on Form S-1, which was filed with the Commission on June 26, 2023, and incorporated herein by reference\n\n \n \n\n(15)\nFiled as Exhibit 4.16 to the Company’s Amendment No. to its Current Report on Form 8-K, which was filed with the Commission on March 28, 2024 and incorporated herein by reference.\n\n \n \n\n(16)\nFiled as Exhibit 10.30 to the Company’s Current Report on Form 8-K, which was filed with the Commission on July 14, 2023.\n\n \n \n\n(17)\nFiled as Exhibit No. 10.31 to the Company’s Current Report on Form 8-K, which was filed with the Commission on December 29, 2023.\n\n \n \n\n(18)\nFiled as Exhibit No.  4.19 to the Company’s Current Report on Form 8-K, which was filed with the Commission on April 23, 2024.\n\n \n \n\n(19)\nFiled as Exhibit No. 10.32 to the Company’s Current Report on Form 8-K, which was filed with the Commission on April 23, 2024.\n\n \n \n\n(20)\nFiled as Exhibit No. 10.33 to the Company’s Current Report on Form 8-K, which was filed with the Commission on May 21, 2024.\n\n \n \n\n(21)\nFiled as Exhibit 3.1D to the Company’s Current Report on form 8-K, filed with the Commission on July 14, 2025.\n\n \n\n*(b) Financial Statement Schedules*\n\n \n\nAll schedules have been omitted because either\nthey are not required, are not applicable or the information is otherwise set forth in the financial statements and related notes thereto.\n\n \n\n4\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the Registrant has duly caused this Amendment to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nDate: May 18, 2026\n\n \n\n \n**NUTRIBAND INC.**\n\n \n \n\n \nBy:\n/s/ Gareth Sheridan \n\n \n \nGareth Sheridan\n\n \n \nChief Executive Officer\n\n \n \n \n\n \nBy:\n/s/ Gerald Goodman \n\n \n \nGerald Goodman\n\n \n \nChief Financial Officer\n\n(Principal Financial and Accounting Officer)\n\n \n\n**Signature**\n \n**Title**\n \n**Date**\n\n \n \n \n \n \n\n/s/ Gareth Sheridan\n \nChief Executive Officer and Director\n \nMay 18, 2026\n\nGareth Sheridan\n \n \n \n \n\n \n \n \n \n \n\n/s/ Serguei Melnik\n \nDirector\n \nMay 18, 2026\n\nSerguei Melnik\n \n \n \n \n\n \n \n \n \n \n\n \nDirector\n \n\nSergei Glinka\n \n \n \n \n\n \n \n \n \n \n\n/s/ Radu Bujoreanu\n \nDirector\n \nMay 18, 2026 \n\nRadu Bujoreanu\n \n \n \n \n\n \n \n \n \n \n\n/s/ Mark Hamilton \n \nDirector\n \nMay 18, 2026 \n\nMark Hamilton\n \n \n \n \n\n \n \n \n \n \n\n/s/ Stefani Mancas\n \nDirector\n \nMay 18, 2026\n\nStefani Mancas\n \n \n \n \n\n \n \n \n \n \n\n/s/ Irina Gram\n \nDirector\n \nMay 18, 2026\n\nIrina Gram\n \n \n \n \n\n \n \n \n \n \n\n \nDirector\n \n \n\nViorica Carlig\n \n \n \n \n\n \n \n \n \n \n\n \nDirector\n \n \n\nAlessandro Pudu\n \n \n \n \n\n \n\n5\n\n \n\n10-K/A\nNo\n0001676047\ntrue\nFY\n0\n0\nNone\n\n0001676047\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nntrb:Warrants1Member\n\n2025-02-01\n2026-01-31\n\n0001676047\n\n2025-07-31\n\n0001676047\n\n2026-05-15\n\niso4217:USD\n\nxbrli:shares"}